Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 90 Lung Neoplasms 34 Meningeal Carcinomatosis 11 Neoplasms 9 Neoplasm Metastasis 7 Adenocarcinoma of Lung 6 Colorectal Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Mesothelioma, Malignant 4 Non-squamous Non-small Cell Lung Cancer 3 NSCLC 3 Mesothelioma 3 Carcinoma 3 Advanced Solid Tumors 3 Non Squamous Non Small Cell Lung Cancer 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Carcinoma, Bronchogenic 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Vaccinia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sexual Dysfunction, Physiological 1 Sarcoma, Ewing 1 Sarcoma 1

Interventions

pembrolizumab 1 Zoledronic Acid 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Chordoma × Pemetrexed × Clear all

NCT06794645 2025-01-27

Pembrolizumab and Pemetrexed for Progressive Chordoma

Saint John's Cancer Institute

Phase 2 Recruiting

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡